Trials / Conditions / Cystic Fibrosis Pulmonary Exacerbation

Cystic Fibrosis Pulmonary Exacerbation

15 registered clinical trials studyying Cystic Fibrosis Pulmonary Exacerbation — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Understanding Inflammation, InFection and Interventions in Severe Exacerbations of Cystic Fibrosis NCT07484607	Alexander Horsley	—
Recruiting	Identifying the Causes and Risk Factors of Pulmonary Exacerbations in Cystic Fibrosis NCT06940531	Alexander Horsley	—
Recruiting	Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study NCT05548283	Chris Goss	Phase 4
Withdrawn	Study to Determine the Efficacy&Safety of ARV-1801(ACG-701) for the Treatment of Cystic Fibrosis Pulmonary Exa NCT05641298	Aceragen	Phase 2
Completed	Efficacy of Intensive Cholecalciferol Monitoring and Supplementation on Serum vitD Levels in Pediatric Patient NCT05276960	Hospital Infantil de Mexico Federico Gomez	Phase 4
Recruiting	Glucose Monitoring in Youth With Cystic Fibrosis During Pulmonary Exacerbations NCT06546943	University of Colorado, Denver	—
Completed	Explore the Sharing Model Intervene to Improve the Knowledge, Attitudes, Service Intentions and Service Start- NCT05407272	Wen-Shiou Pan	N/A
Terminated	Sensor Augmented Pump (SAP) Therapy for Inpatient CFRD Management NCT03939065	University of Colorado, Denver	N/A
Unknown	Markers of Pulmonary Dysbiosis Associated With Exacerbation in Patients Followed for Cystic Fibrosis NCT03569904	University Hospital, Grenoble	—
Terminated	A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic NCT03309358	Synspira, Inc.	Phase 1
Unknown	Program Of Exercises During The Hospitalization Of Children And Adolescents With Cystic Fibrosis NCT03273959	Hospital de Clinicas de Porto Alegre	N/A
Completed	Prednisone in Cystic Fibrosis Pulmonary Exacerbations NCT03070522	The Hospital for Sick Children	Phase 3
Completed	Population Pharmacokinetics and Safety of Intravenous Ceftolozane/Tazobactam in Adult Cystic Fibrosis Patients NCT02421120	Joseph L. Kuti, PharmD	Phase 4
Completed	Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patien NCT02109822	University of Washington	—
Terminated	Pharmacokinetic Study of Extended Infusion Meropenem in Adult Cystic Fibrosis Patients NCT01158937	Unity Health Toronto	N/A